1887

Abstract

Avian hepatitis E virus (avian HEV) is genetically and antigenically related to human HEV, the causative agent of hepatitis E. To identify the neutralizing epitopes on the capsid (ORF2) protein of avian HEV, four mAbs (7B2, 1E11, 10A2 and 5G10) against recombinant avian HEV ORF2 protein were generated. mAbs 7B2, 1E11 and 10A2 blocked each other for binding to avian HEV ORF2 protein in a competitive ELISA, whereas 5G10 did not block the other mAbs, suggesting that 7B2, 1E11 and 10A2 recognize the same or overlapping epitopes and 5G10 recognizes a different one. The epitopes recognized by 7B2, 1E11 and 10A2, and by 5G10 were mapped by Western blotting between aa 513 and 570, and between aa 476 and 513, respectively. mAbs 1E11, 10A2 and 5G10 were shown to bind to avian HEV particles , although only 5G10 reacted to viral antigens in transfected LMH cells. To assess the neutralizing activities of the mAbs, avian HEV was incubated with each mAb before inoculation into specific-pathogen-free chickens. Both viraemia and faecal virus shedding were delayed in chickens inoculated with the mixtures of avian HEV and 1E11, 10A2 or 5G10, suggesting that these three mAbs partially neutralize avian HEV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83366-0
2008-02-01
2019-11-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/2/500.html?itemId=/content/journal/jgv/10.1099/vir.0.83366-0&mimeType=html&fmt=ahah

References

  1. Amon, J. J., Drobeniuc, J., Bower, W. A., Magana, J. C., Escobedo, M. A., Williams, I. T., Bell, B. P. & Armstrong, G. L. ( 2006; ). Locally acquired hepatitis E virus infection, El Paso, Texas. J Med Virol 78, 741–746.[CrossRef]
    [Google Scholar]
  2. Baccala, R., Quang, T. V., Gilbert, M., Ternynck, T. & Avrameas, S. ( 1989; ). Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes. Proc Natl Acad Sci U S A 86, 4624–4628.[CrossRef]
    [Google Scholar]
  3. Billam, P., Huang, F. F., Sun, Z. F., Pierson, F. W., Duncan, R. B., Elvinger, F., Guenette, D. K., Toth, T. E. & Meng, X. J. ( 2005; ). Systematic pathogenesis and replication of avian hepatitis E virus in specific-pathogen-free adult chickens. J Virol 79, 3429–3437.[CrossRef]
    [Google Scholar]
  4. Bryan, J. P., Tsarev, S. A., Iqbal, M., Ticehurst, J., Emerson, S., Ahmed, A., Duncan, J., Rafiqui, A. R., Malik, I. A. & Purcell, R. H. ( 1994; ). Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 170, 517–521.[CrossRef]
    [Google Scholar]
  5. Emerson, S. U. & Purcell, R. H. ( 2001; ). Recombinant vaccines for hepatitis E. Trends Mol Med 7, 462–466.[CrossRef]
    [Google Scholar]
  6. Emerson, S. U. & Purcell, R. H. ( 2003; ). Hepatitis E virus. Rev Med Virol 13, 145–154.[CrossRef]
    [Google Scholar]
  7. Emerson, S. U., Anderson, D., Arankalle, A., Meng, X. J., Purdy, M., Schlauder, G. G. & Tsarev, S. A. ( 2004; ). Hepevirus. In Virus Taxonomy, Eighth Report of the International Committee on Taxonomy of Viruses, pp. 851–855. Edited by C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger & L. A. Ball. London: Elsevier Academic Press.
  8. Emerson, S. U., Clemente-Casares, P., Moiduddin, N., Arankalle, V. A., Torian, U. & Purcell, R. H. ( 2006; ). Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol 87, 697–704.[CrossRef]
    [Google Scholar]
  9. Guo, H., Zhou, E. M., Sun, Z. F., Meng, X. J. & Halbur, P. G. ( 2006; ). Identification of B-cell epitopes in the capsid protein of avian hepatitis E virus (avian HEV) that are common to human and swine HEVs or unique to avian HEV. J Gen Virol 87, 217–223.[CrossRef]
    [Google Scholar]
  10. Guo, H., Zhou, E. M., Sun, Z. F. & Meng, X. J. ( 2007a; ). Egg whites from eggs of chickens infected experimentally with avian hepatitis E virus contain infectious virus, but evidence of complete vertical transmission is lacking. J Gen Virol 88, 1532–1537.[CrossRef]
    [Google Scholar]
  11. Guo, H., Zhou, E. M., Sun, Z. F. & Meng, X. J. ( 2007b; ). Protection of chickens against avian hepatitis E virus (avian HEV) infection by immunization with recombinant avian HEV capsid protein. Vaccine 25, 2892–2899.[CrossRef]
    [Google Scholar]
  12. Haqshenas, G., Shivaprasad, H. L., Woolcock, P. R., Read, D. H. & Meng, X. J. ( 2001; ). Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis–splenomegaly syndrome in the United States. J Gen Virol 82, 2449–2462.
    [Google Scholar]
  13. Haqshenas, G., Huang, F. F., Fenaux, M., Guenette, D. K., Pierson, F. W., Larsen, C. T., Shivaprasad, H. L., Toth, T. E. & Meng, X. J. ( 2002; ). The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus. J Gen Virol 83, 2201–2209.
    [Google Scholar]
  14. Huang, F. F., Sun, Z. F., Emerson, S. U., Purcell, R. H., Shivaprasad, H. L., Pierson, F. W., Toth, T. E. & Meng, X. J. ( 2004; ). Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J Gen Virol 85, 1609–1618.[CrossRef]
    [Google Scholar]
  15. Huang, F. F., Pierson, F. W., Toth, T. E. & Meng, X. J. ( 2005; ). Construction and characterization of infectious cDNA clones of a chicken strain of hepatitis E virus (HEV), avian HEV. J Gen Virol 86, 2585–2593.[CrossRef]
    [Google Scholar]
  16. Im, S. W., Zhang, J. Z., Zhuang, H., Che, X. Y., Zhu, W. F., Xu, G. M., Li, K., Xia, N. S. & Ng, M. H. ( 2001; ). A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 19, 3726–3732.[CrossRef]
    [Google Scholar]
  17. Konishi, E. ( 1997; ). Monoclonal antibodies multireactive with parasite antigens produced by hybridomas generated from naive mice. Parasitology 115, 387–393.[CrossRef]
    [Google Scholar]
  18. Li, C., Candotti, D. & Allain, J. P. ( 2001; ). Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hypervariable region 1. J Virol 75, 12412–12420.[CrossRef]
    [Google Scholar]
  19. Li, T. C., Suzaki, Y., Ami, Y., Dhole, T. N., Miyamura, T. & Takeda, N. ( 2004; ). Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 22, 370–377.[CrossRef]
    [Google Scholar]
  20. Li, S. W., Zhang, J., Li, Y. M., Ou, S. H., Huang, G. Y., He, Z. Q., Ge, S. X., Xian, Y. L., Pang, S. Q. & other authors ( 2005; ). A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23, 2893–2901.[CrossRef]
    [Google Scholar]
  21. Mansuy, J. M., Peron, J. M., Abravanel, F., Poirson, H., Dubois, M., Miedouge, M., Vischi, F., Alric, L., Vinel, J. P. & other authors ( 2004; ). Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 74, 419–424.[CrossRef]
    [Google Scholar]
  22. Meng, X. J., Purcell, R. H., Halbur, P. G., Lehman, J. R., Webb, D. M., Tsareva, T. S., Haynes, J. S., Thacker, B. J. & Emerson, S. U. ( 1997; ). A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A 94, 9860–9865.[CrossRef]
    [Google Scholar]
  23. Meng, X. J., Wiseman, B., Elvinger, F., Guenette, D. K., Toth, T. E., Engle, R. E., Emerson, S. U. & Purcell, R. H. ( 2002; ). Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 40, 117–122.[CrossRef]
    [Google Scholar]
  24. Mizuo, H., Yazaki, Y., Sugawara, K., Tsuda, F., Takahashi, M., Nishizawa, T. & Okamoto, H. ( 2005; ). Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 76, 341–349.[CrossRef]
    [Google Scholar]
  25. Nawagitgul, P., Harms, P. A., Morozov, I., Thacker, B. J., Sorden, S. D., Lekcharoensuk, C. & Paul, P. S. ( 2002; ). Modified indirect porcine circovirus (PCV) type 2-based and recombinant capsid protein (ORF2)-based enzyme-linked immunosorbent assays for detection of antibodies to PCV. Clin Diagn Lab Immunol 9, 33–40.
    [Google Scholar]
  26. Purcell, R. H., Nguyen, H., Shapiro, M., Engle, R. E., Govindarajan, S., Blackwelder, W. C., Wong, D. C., Prieels, J. P. & Emerson, S. U. ( 2003; ). Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 21, 2607–2615.[CrossRef]
    [Google Scholar]
  27. Purdy, M. A., McCaustland, K. A., Krawczynski, K., Spelbring, J., Reyes, G. R. & Bradley, D. W. ( 1993; ). Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J Med Virol 41, 90–94.
    [Google Scholar]
  28. Riddell, M. A., Li, F. & Anderson, D. A. ( 2000; ). Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J Virol 74, 8011–8017.[CrossRef]
    [Google Scholar]
  29. Robinson, R. A., Burgess, W. H., Emerson, S. U., Leibowitz, R. S., Sosnovtseva, S. A., Tsarev, S. & Purcell, R. H. ( 1998; ). Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif 12, 75–84.[CrossRef]
    [Google Scholar]
  30. Sadler, G. J., Mells, G. F., Shah, N. H., Chesner, I. M. & Walt, R. P. ( 2006; ). UK acquired hepatitis E – an emerging problem? J Med Virol 78, 473–475.[CrossRef]
    [Google Scholar]
  31. Schick, M. R., Dreesman, G. R. & Kennedy, R. C. ( 1987; ). Induction of an anti-hepatitis B surface antigen response in mice by noninternal image (Ab2 alpha) anti-idiotypic antibodies. J Immunol 138, 3419–3425.
    [Google Scholar]
  32. Schofield, D. J., Glamann, J., Emerson, S. U. & Purcell, R. H. ( 2000; ). Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J Virol 74, 5548–5555.[CrossRef]
    [Google Scholar]
  33. Schofield, D. J., Purcell, R. H., Nguyen, H. T. & Emerson, S. U. ( 2003; ). Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine. Vaccine 22, 257–267.[CrossRef]
    [Google Scholar]
  34. Shrestha, M. P., Scott, R. M., Joshi, D. M., Mammen, M. P., Jr, Thapa, G. B., Thapa, N., Myint, K. S., Fourneau, M., Kuschner, R. A. & other authors ( 2007; ). Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 356, 895–903.[CrossRef]
    [Google Scholar]
  35. Sun, Z. F., Larsen, C. T., Huang, F. F., Billam, P., Pierson, F. W., Toth, T. E. & Meng, X. J. ( 2004; ). Generation and infectivity titration of an infectious stock of avian hepatitis E virus (HEV) in chickens and cross-species infection of turkeys with avian HEV. J Clin Microbiol 42, 2658–2662.[CrossRef]
    [Google Scholar]
  36. Tam, A. W., Smith, M. M., Guerra, M. E., Huang, C. C., Bradley, D. W., Fry, K. E. & Reyes, G. R. ( 1991; ). Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185, 120–131.[CrossRef]
    [Google Scholar]
  37. Tsarev, S. A., Tsareva, T. S., Emerson, S. U., Govindarajan, S., Shapiro, M., Gerin, J. L. & Purcell, R. H. ( 1994; ). Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A 91, 10198–10202.[CrossRef]
    [Google Scholar]
  38. Zhang, M., Emerson, S. U., Nguyen, H., Engle, R. E., Govindarajan, S., Gerin, J. L. & Purcell, R. H. ( 2001; ). Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 20, 853–857.[CrossRef]
    [Google Scholar]
  39. Zhang, J., Gu, Y., Ge, S. X., Li, S. W., He, Z. Q., Huang, G. Y., Zhuang, H., Ng, M. H. & Xia, N. S. ( 2005; ). Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23, 2881–2892.[CrossRef]
    [Google Scholar]
  40. Zhou, E. & Afshar, A. ( 1999; ). Characterisation of monoclonal antibodies to epizootic hemorrhagic disease virus of deer (EHDV) and bluetongue virus by immunisation of mice with EHDV recombinant VP7 antigen. Res Vet Sci 66, 247–252.[CrossRef]
    [Google Scholar]
  41. Zhou, Y. H., Purcell, R. H. & Emerson, S. U. ( 2004; ). An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22, 2578–2585.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83366-0
Loading
/content/journal/jgv/10.1099/vir.0.83366-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error